Published in J Immunol on November 01, 1997
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med (2004) 9.11
The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol (2013) 3.53
CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J Clin Invest (2002) 2.63
The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med (1999) 2.62
Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci U S A (1998) 2.29
Regional and mucosal memory T cells. Nat Immunol (2011) 2.21
CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol (2005) 2.02
Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol (2001) 1.87
Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity (2013) 1.49
Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut (2006) 1.36
Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol (2012) 1.35
Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection. PLoS Pathog (2012) 1.26
Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J Clin Invest (2003) 1.25
T-cell activation in the intestinal mucosa. Immunol Rev (2007) 1.20
An opposite pattern of selection of a single T cell antigen receptor in the thymus and among intraepithelial lymphocytes. J Exp Med (1998) 0.99
Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect Immun (2000) 0.98
Location, location, location: tissue-specific regulation of immune responses. J Leukoc Biol (2013) 0.96
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation. J Immunol (2008) 0.93
Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. J Infect Dis (2011) 0.90
Ups and downs of mucosal cellular immunity against protozoan parasites. Infect Immun (2001) 0.87
Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells. J Immunol (2015) 0.85
Synthesis and delivery of short, noncoding RNA by B lymphocytes. Proc Natl Acad Sci U S A (2013) 0.80
Mucosal T lymphocytes--peacekeepers and warriors. Springer Semin Immunopathol (2005) 0.79
Geography and plumbing control the T cell response to infection. Immunol Cell Biol (2008) 0.79
Activation of human intraepithelial lymphocytes reduces CD3 expression. Clin Exp Immunol (2003) 0.77
Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C. Curr Immunol Rev (2005) 0.77
Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients. Front Immunol (2016) 0.75
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Preferential localization of effector memory cells in nonlymphoid tissue. Science (2001) 14.22
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol (2000) 12.81
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature (1988) 4.89
Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol (2001) 4.38
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol (2001) 2.41
Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci U S A (1998) 2.29
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J Immunol (1995) 2.18
The use of pictograms improves symptom evaluation by patients with functional dyspepsia. Aliment Pharmacol Ther (2014) 2.06
Grading impairment in leprosy. Lepr Rev (1999) 2.02
N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol (1986) 2.01
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol (1999) 1.97
Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J Immunol (2001) 1.84
Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82
Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73
Differential expression of the leucocyte-common antigen family. Immunol Today (1988) 1.70
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity (2000) 1.67
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J Immunol (1999) 1.53
Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies. Nature (1985) 1.51
Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol (1997) 1.50
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43
Universal optical conductance of graphite. Phys Rev Lett (2008) 1.41
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol (2012) 1.35
Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J Exp Med (1989) 1.35
Age-dependent intestinal lymphoproliferative disorder due to stem cell factor receptor deficiency: parameters in small and large intestine. J Immunol (1997) 1.34
Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches. J Exp Med (2000) 1.34
Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques. Vet Pathol (2010) 1.31
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature (1999) 1.23
B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20
SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens (2006) 1.20
Antigen-specific CD8+ T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur J Immunol (1997) 1.18
Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. Immunity (1994) 1.13
Novel antigenic determinants of the T200 glycoprotein expressed preferentially by activated cytotoxic T lymphocytes. J Immunol (1985) 1.13
Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev (1998) 1.10
Immunity or tolerance? That is the question for dendritic cells. Nat Immunol (2001) 1.09
Quantum critical behaviour in a high-T(c) superconductor. Nature (2003) 1.09
Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol (1994) 1.08
Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J Virol (2000) 1.07
pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. J Immunol Methods (1991) 1.07
T cell receptor-triggered activation of intraepithelial lymphocytes in vitro. Int Immunol (1993) 1.04
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol (2000) 1.01
A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol (2001) 1.01
Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc Natl Acad Sci U S A (1993) 1.00
The role of IL-7 in thymic and extrathymic development of TCR gamma delta cells. J Immunol (1998) 1.00
Beta2 integrins and ICAM-1 are involved in establishment of the intestinal mucosal T cell compartment. Immunity (1996) 0.98
Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes. J Immunol (1989) 0.96
Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus. J Gen Virol (2000) 0.96
Deletion of high-avidity T cells by thymic epithelium. Proc Natl Acad Sci U S A (1995) 0.95
The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol (1998) 0.95
Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes (2001) 0.94
Circulating insulin-like growth factors-I and -II and substrates in fetal sheep following restriction of placental growth. J Endocrinol (1994) 0.92
Condom use with regular and casual partners among women attending family planning clinics. Fam Plann Perspect (1992) 0.91
Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells. J Exp Med (1994) 0.90
Rectal perforations. Personal experience and literature review. Minerva Chir (2002) 0.90
Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci U S A (1992) 0.90
Assessing behavioral risk for HIV infection in family-planning and STD clinics: similarities and differences. Sex Transm Dis (1990) 0.89
Inhibition of naïve class I-restricted T cells by altered peptide ligands. Immunol Cell Biol (1999) 0.89
[Granulomatous myopathy]. Acta Neurol Psychiatr Belg (1966) 0.88
Ghrelin signaling in the gut, its physiological properties, and therapeutic potential. Neurogastroenterol Motil (2013) 0.87
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines. Eur J Immunol (2000) 0.87
Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int Immunol (1997) 0.87
Structural changes in the promoter region mediate transvection at the sn-glycerol-3-phosphate dehydrogenase gene of Drosophila melanogaster. Biochem Genet (1999) 0.86
Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity. Novartis Found Symp (1998) 0.86
Down-modulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell Immunol (1997) 0.85
Anastomotic pseudoaneurysm complicating renal transplantation: treatment options. Eur J Vasc Endovasc Surg (2010) 0.84
Selection of intestinal intraepithelial lymphocyte T cell receptors: evidence for a dynamic tissue-specific process. Int Immunol (1993) 0.84
The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol Cell Biol (1999) 0.83
Phase delay of the rhythm of 6-sulphatoxy melatonin excretion by artificial light. J Pineal Res (1987) 0.83
Aerobiology and inhalation exposure to biological select agents and toxins. Vet Pathol (2010) 0.83
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. J BUON (2011) 0.82
Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients. Int J Lepr Other Mycobact Dis (1997) 0.82
Proteolytic degradation of rat growth hormone-releasing factor(1-29) amide in rat pituitary and hypothalamus. Brain Res (1993) 0.82
Ras gene mutations in vinyl chloride-induced liver tumours are carcinogen-specific but vary with cell type and species. Int J Cancer (2000) 0.82
Novel IL-15 isoforms generated by alternative splicing are expressed in the intestinal epithelium. Genes Immun (2006) 0.82
Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7. J Immunol (1999) 0.81
Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein. Eur J Immunol (1981) 0.79
Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol (1998) 0.79
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients. J Neural Transm Suppl (1989) 0.78
Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants. Vaccine (2008) 0.78
Requirement for extrathymic class I histocompatibility antigens for positive selection of thymus-derived T lymphocytes. J Immunol (1995) 0.78
Outpatient management of superficial temporal artery aneurysms. J Cardiovasc Surg (Torino) (2001) 0.78
Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma. J Hepatol (2000) 0.78
Glycosyltransferase regulation mediated by pre-TCR signaling in early thymocyte development. Int Immunol (1998) 0.78